Gilead Seeks Win In Gov't's 'Unprecedented' HIV Drug IP Suit

By Dorothy Atkins (October 27, 2022, 9:53 PM EDT) -- Gilead asked a Delaware federal court to hand it a win Thursday in the government's suit alleging its PrEP HIV drugs infringe the U.S. Department of Health and Human Services' patents, arguing that the lawsuit is "extraordinary and unprecedented" and HHS doesn't have the authority to sue for infringement....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!